For decades, Alzheimer’s disease has been framed as a one‑way slide, a slow erasure of memory that medicine could at best delay. That narrative is starting to crack. A wave of lab discoveries, smarter ...

Dr. Yoshiteru Shimoide, immunologist and director of the Yoshiteru Shimoide Internal Medicine Clinic in Kagoshima, Japan, has developed RO‑8, the world’s first therapeutic agent designed to ...

Researchers from the NeuroAD group (Neuropathology of Alzheimer's Disease) within the Department of Cell Biology, Genetics and Physiology at the University of Málaga, also affiliated with ...

By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...

Growing evidence suggests that the key to treating Alzheimer's is catching it in its earliest stages. Now scientists have developed a promising new drug that seems to be effective at stalling the ...

In the last few years, progress has been made in the fight against Alzheimer’s disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These monoclonal anti-Aβs are proteins made ...

A new blood test could predict when Alzheimer’s will strike — years before symptoms begin. Scientists at Washington University School of Medicine in St. Louis have created a way to estimate when a ...

A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than previously believed. The research also found that over one in ten people aged 70 ...

Creatine showed promising results in a pilot study with Alzheimer's patients, and this has been backed by an expert on The ...